{"id":521180,"date":"2021-08-02T08:04:26","date_gmt":"2021-08-02T12:04:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/"},"modified":"2021-08-02T08:04:26","modified_gmt":"2021-08-02T12:04:26","slug":"establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/","title":{"rendered":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit"},"content":{"rendered":"

<\/p>\n

\nEstablishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit\n<\/p>\n

SANTA BARBARA, Calif.–(BUSINESS WIRE<\/a>)–
\nEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the UBS Genomics 2.0 and MedTech Innovations Summit, which is being held August 10-12, 2021. Mr. Chac\u00f3n-Quir\u00f3s and Mr. Denhoy are scheduled to speak to conference attendees at 8:00 am ET on Thursday, August 12, 2021.\n<\/p>\n

\nA live webcast of the presentation will be available to all interested parties on the Establishment Labs investor relations website at https:\/\/investors.establishmentlabs.com\/<\/a>. An archived version of the webcast will be available on the same website following the completion of the event.\n<\/p>\n

About Establishment Labs<\/span><\/b><\/p>\n

\nEstablishment Labs Holdings Inc. is a global medical technology company dedicated to improving women\u2019s health and wellness. The company\u2019s initial focus is breast health, principally breast aesthetics and reconstruction. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants\u00ae<\/sup> that include a number of innovative and patented features designed to deliver improved aesthetic and clinical outcomes. Since commercial launch in 2010, more than 1.6 million Motiva Implants\u00ae<\/sup> have been delivered to plastic surgeons in over 80 countries. The company also offers or has under development a number of related products and technologies, including the Motiva Flora\u00ae<\/sup> tissue expander and Motiva MIA\u00ae<\/sup>, the company\u2019s minimally invasive breast enhancement procedure. In 2018, Establishment Labs received an investigational device exemption (IDE) from the FDA for the Motiva Implant\u00ae<\/sup> and began a clinical trial to support regulatory approval in the United States. Motiva Implants\u00ae<\/sup> are manufactured at the company\u2019s two facilities in Costa Rica, which are compliant with all applicable regulatory standards under ISO13485:2016 and FDA 21 CFR 820 under the MDSAP program. Please visit our website for additional information at www.establishmentlabs.com<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210802005264\/en\/<\/a><\/span><\/p>\n

Investor\/Media Contact:
\n<\/b>
Raj Denhoy
\n
415-828-1044
\n
rdenhoy@establishmentlabs.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Surgery Health Other Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit SANTA BARBARA, Calif.–(BUSINESS WIRE)– Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the UBS Genomics 2.0 and MedTech Innovations Summit, which is being held August 10-12, 2021. Mr. Chac\u00f3n-Quir\u00f3s and Mr. Denhoy are scheduled to speak to conference attendees at 8:00 am ET on Thursday, August 12, 2021. A live webcast of the presentation will be available to all interested parties on the … <\/p>\n

Continue reading “Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521180","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEstablishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit SANTA BARBARA, Calif.–(BUSINESS WIRE)– Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the UBS Genomics 2.0 and MedTech Innovations Summit, which is being held August 10-12, 2021. Mr. Chac\u00f3n-Quir\u00f3s and Mr. Denhoy are scheduled to speak to conference attendees at 8:00 am ET on Thursday, August 12, 2021. A live webcast of the presentation will be available to all interested parties on the … Continue reading "Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T12:04:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit\",\"datePublished\":\"2021-08-02T12:04:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/\",\"name\":\"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-08-02T12:04:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/","og_locale":"en_US","og_type":"article","og_title":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit - Market Newsdesk","og_description":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit SANTA BARBARA, Calif.–(BUSINESS WIRE)– Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women\u2019s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan Jos\u00e9 Chac\u00f3n-Quir\u00f3s, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the UBS Genomics 2.0 and MedTech Innovations Summit, which is being held August 10-12, 2021. Mr. Chac\u00f3n-Quir\u00f3s and Mr. Denhoy are scheduled to speak to conference attendees at 8:00 am ET on Thursday, August 12, 2021. A live webcast of the presentation will be available to all interested parties on the … Continue reading \"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T12:04:26+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit","datePublished":"2021-08-02T12:04:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/"},"wordCount":386,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/","name":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-08-02T12:04:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005264r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/establishment-labs-announces-participation-in-the-ubs-genomics-2-0-and-medtech-innovations-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521180"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521180\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}